After 60 MeOH and water extracts of natural crude drugs were screened for their ability to stimulate osteoblast proliferation, four MeOH extracts (Cynomorium songaricum, Drynaria fortunei, Lycium chinense, Rehmannia glutinosa) and seven water extracts (Cornus officinalis, Dendrobium nobile, Dioscorea spongiosa, Drynaria fortunei, Eucommia ulmoides, Lycium chinensis, Viscum coloratum) showed that potent activities were evaluated for inhibition of osteoclast formation. The results indicated that the water extract of D. spongiosa not only showed the strongest stimulation of osteoblast proliferation but also possessed potent inhibitory activity aganist osteoclast formation, whereas it showed lower cytotoxicity in osteoblast and bone marrow cells. A further in vivo experiment determined the antiosteoporotic activity of this extract, in which it inhibited the decrease in cancellous bone mineral content, cancellous bone mineral density, and cortical bone mineral content of the proximal tibia in ovariectomized rats.
Osteoporosis, the most frequent bone remodeling disease, is defined by a low bone mass and a high risk of fractures. It is caused by a relative increase of osteoclastic bone resorption over osteoblastic bone formation. 1) Since ipriflavone was approved for the treatment of osteoporosis in the 1980s, natural plants have been researched. In traditional Chinese medicine, herbs that tonify the kidney (hojin, ) and strengthen the bone can be used for the treatment of bone diseases with the same symptoms as osteoporosis.
2) The currently available treatment, e.g., estrogen replacement treatment, is based on inhibition of bone resorption to prevent further bone loss. Many osteoporotic patients, however, have already lost a substantial amount of bone, and thus a method to increase bone mass by stimulating new bone formation is needed. 3) In bone formation, osteoblasts are the key cell in bone matrix formation and calcification. 4) Thus we screened water and MeOH extracts from 30 Chinese herbs that have effects on kidney and bone to determine whether they influence the proliferation of the osteoblast-like UMR106 cell line. As the excellent antiosteoporotic therapy should act on both bone formation and bone resorption, we also examined the effect of active extracts against the formation of tartrateresistant acid phosphatase (TRAP)-positive osteoclast-like multinucleated cells. Based on the results of both assays, the water extract of Dioscorea spongiosa, which showed the strongest in vitro antiosteoporotic activity, was selected and subjected to in vivo experiment using ovariectomized (OVX) rats as a model of postmenopausal bone loss.
MATERIALS AND METHODS
General Aged female rats (Wistar) and mice (ddY) were purchased from Sankyo Labo Service (Tokyo, Japan). The osteoblast-like UMR 106 cell line was from Beijing Medical University, Beijing, China (originating from the Massachusetts General Hospital, Boston, MA, U.S.A.). Fetal bovine serum (FBS) was from JRH Biosciences; alpha modified Ea- Plant Materials All crude drugs used in the experiments were purchased from Tianrentan Pharmaceutical Company (Shenyang, China) and identified by Professor Qishi Sun (Division of Pharmacognosy, Shenyang Pharmaceutical University). A voucher specimen (SPU 1120-1149) of each plant was deposited in the Herbarium of Shenyang Pharmaceutical University, Shenyang, China.
Preparation of Extracts Powdered crude drug (5 g each) was extracted with refluxing methanol (20 ml each, three times) for 1 h. The methanol extracts were filtered and the combined filtrate was concentrated in vacuo and then lyophilized. Similarly, water extracts were also obtained by extracting with distilled water.
Stimulation of Proliferation of Osteoblast-Like UMR106 Cell Line Osteoblast-like UMR106 cells were suspended in a-MEM and the suspension (200 ml) containing 8000 cells was plated in 96-well plates. The cells were preincubated at 37°C in a humidified atmosphere containing 5% CO 2 for 24 h in a-MEM containing 7% FBS to attach the cells and then for another 24 h in a-MEM without FBS. The cells were treated with test specimens (40, 400 mg/ml) in a-MEM without FBS and incubated for 48 h under the same conditions. Then, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to each well and the plates were incubated for 4 h. The amount of formazan formed was measured spectrophotometrically at 590 nm with a Bio-RAD Model 3550 plate reader. Samples were dissolved in 5% DMSO and then diluted with the medium. NaF (10 Ϫ5 M) was used as a positive control. Proliferation rates were calculated from the mean values of the data from four wells.
5)
Inhibition of Formation of Osteoclast-Like Multinucleated Cells Osteoclast-like multinucleated cells were origi- nated from a coculture of mouse bone marrow cells and mouse primary osteoblastic cells using the method of Takahashi et al. 6) Osteoblastic cells were prepared from neonatal mouse calvarias and plated at 10 4 cells/well in a-MEM containing 10% FBS. The marrow cavity of the tibiae of male ddY mice (7 weeks old) was flushed with a-MEM and cocultured with the osteoblastic cells at 10 5 cells/well in the presence of 1a,25(OH) 2 D 3 (10 Ϫ7 M) and test samples at various concentrations. Elcitonin (2 U/ml) was used as a positive control. The medium was replaced with new medium containing test samples and 1a,25(OH) 2 D 3 every 2 d. All cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . After culture for 6 d, adherent cells were fixed with a solution of 10% formalin in phosphate-buffered saline (pH 7.2) for 10 min, dehydrated with ethanol-acetone (50 : 50, v/v) for 45 s, and stained for TRAP for 12 min at room temperature. Cells possessing three or more nuclei were counted as osteoclast-like multinucleated cells under inverted microscope.
Rats Experiments Aged female Wistar rats (8 months, 260-330 g) were maintained on a 12-h light/dark cycle in a temperature-and humidity-controlled room. The animals were allowed free access to laboratory pellet chew (CE-2; CLEA Japan Inc., Tokyo, Japan) and water ad libitum during the experiment. After 7 d of acclimatization, all animals were anesthetized with pentobarbital (40 mg/kg, i.p.), and both ovaries were exposed. The ovaries of all animals, except those of sham-operated group, were ligated and then removed. Sham operation was performed by only exposing the ovaries. From 2 weeks after ovariectomy, the water extract of D. spongiosa (50 mg/kg or 100 mg/kg) dissolved in distilled water and was administered orally 6 times a week to the rats. 17b-Estradiol (E 2 ) was dissolved in a mixture of benzyl alcohol (5%) and corn oil (95%) and 0.1 mg/kg was administered to the rats by intraperitoneal injection. Six weeks after the start of intervention, all animals were anesthetized with an intraperitoneal injection of pentobarbital and subjected to peripheral quantitative computed tomography (pQCT) measurement. At autopsy, the uteri were removed and weighed.
pQCT Analysis The left tibiae were scanned with a pQCT system XCT Research M (Stratec Medizintechnik GmbH, Germany). The voxel size was 0.08 mm, the slice thickness was 0.5 mm, and the cortical threshold was 464 mg/cm 3 . We used the measuring mode for dividing total bone into cortical bone or cancellous bone as peel mode 20. This mode can detect the inner threshold automatically. After a scout scan was obtained and the growth plate was identified, transverse image sets of four cross-sectional slices were scanned at a 1-5-mm region of the left proximal tibia below the proximal separation point between the femur and tibia. From each transverse image, bone mineral content (BMC), bone mineral density (BMD), and area in the total region were measured. The cortical region was extracted from the total bone region using specific algorithms (separation mode 3 and contour mode 2), and cortical and cancellous BMC, BMD, cortical thickness, periosteal and endosteal circum- 
RESULTS AND DISCUSSION
The clonal osteoblast-like UMR 106 cell line, derived from a rat osteogenic sarcoma, has many of the enzymatic properties of normal osteoblasts (including high alkaline phosphatase activity and parathyroid hormone-simulated adenyl cyclase activity). 7, 8) They produce bone-specific type I collagen and have similar resting membrane potentials to those of osteoblasts.
9) Taking advantage of their higher purity and faster proliferation rate than those of osteoblasts, UMR106 cells were used for screening of the stimulation of 30 traditional Chinese herbs of bone formation. Four MeOH extracts (Cynomorium songaricum, Drynaria fortunei, Lycium chinense, Rehmannia glutinosa) and seven water extracts (Cornus officinalis, Dendrobium nobile, D. spongiosa, Drynaria fortunei, Eucommia ulmoides, Lycium chinense, Viscum coloratum) showed potent activity (Table 1) , identical or stronger than the positive control NaF, which is used to treat osteoporosis and was reported to simulate proliferation of bone-forming cells. 10) Among the 11 active extracts, the water extract of rhizomes of D. spongiosa showed the strongest activity, with a stimulation rate of 67%.
We determined the inhibitory activity of these 11 extracts on the formation of osteoclast-like cells. When mouse osteoblastic cells and bone marrow cells were cocultured in the presence of 1a,25-dihydroxyvitamin D 3 , osteoclast-like cells formed. Evidence has confirmed that these osteoclast-like cells are true osteoclasts, i.e., primary bone-resorbing cells.
11) Among the 11 extracts examined, the water extracts of D. spongiosa, L. chinense, and V. coloratum and the MeOH extract of L. chinense showed high inhibition rates at the dose of 20 mg/ml (Table 2) . However, extracts with more than 90% inhibition all showed strong cytotoxicity against osteoblasts and bone marrow cells (Fig. 1c) . At high concentration, the water extract of D. spongiosa also showed cytotoxicity, but at a low concentration, it appeared to inhibit formation of osteoclasts from osteoblasts and bone morrow cells without and cytotoxicity (Fig. 1b) . Thus the water extract of D. spongiosa was considered to be the most likely antiosteoporotic agent among the 60 screened extracts.
The antiosteoporotic effect of the water extract of D. spongiosa was examined in OVX rats, an animal model of postmenopausal bone loss. After ovariectomy, the rats showed a significant increase in body weight and decrease in uterine weight due to estrogen deficiency (Fig. 2) . pQCT measurement indicated a loss of total bone mass and decrease in bone strength in the proximal tibia (Table 3) . Treatment with 100 mg/kg/d of the water extract of D. spongiosa significantly prevented the decrease in the BMC and BMD of can- cellous bone and BMC of cortical bone (Table 3) , without side effects on the uterus (Fig. 2) . Moreover, the water extract slightly increased the periosteal circumstance and inhibited the elevation of the endosteal circumstance. Thus the water extract may stimulate bone formation and inhibit bone resorption. These results together with in vitro data indicate that the water extract of D. spongiosa has antiosteoporotic activity. Preliminary investigation of the water extract indicated that it contains large quantities of steroidal saponins.
Steroidal saponins were reported to maintain the bone health of premenopausal and menopausal women. 12) Thus the steroidal saponin content may play an important role in the antiosteoporotic activity of the water extract of D. spongiosa.
D. spongiosa is distributed in the southern part of the People's Republic of China and is used for the treatment of rheumatism and urethral and renal infection in traditional Chinese medicine. 13) Although its water extract is reported to have antiatherosclerotic activity, 14) this is the first report on its antiosteoporotic activity.
